Sri Krishna Pharmaceuticals Ltd.
SRI KRISHNA PHARMACEUTICALS LTD (SKPL), with exports to over 75 countries, offers innovative solutions across the value chain. With 3 API manufacturing facilities with multiple chemistry capabilities, SKPL offers APAP / PARACETAMOL, DOMPERIDONE, FUROSEMIDE, GLIBENCLAMIDE, GLIPIZIDE and FOLIC ACID. The manufacturing sites are spread around the Hyderabad city’s industrial belts and are approved by major international health authorities like US FDA, EDQM, COFEPRIS, HEALTH CANADA and others.
With the new oral finished dosage form facility SKPL will be offering GENERIC orals with capacity of 1.2 Billion / annum and also CMO opportunities.
With over 35 years of manufacturing experience, sustainability, customer support and supplies - SKPL continue to grow its presence in the market with larger basket of products supported with both backward and forward integration of process.